SEC Comment Letter for ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052) (AVXL) — Mar 30, 2011

ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)
Date: March 30, 2011 · CIK: 0001314052 · Accession: 0000000000-11-019526

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

March 22, 2011

Author

Melissa N. Rocha

Form

UPLOAD

Company

ANAVEX LIFE SCIENCES CORP. (AVXL) (CIK 0001314052)

Letter

March 22, 2011 Dr. Cameron Durant Executive Chairman and Director Anavex Life Sciences Corp. 50 Harrison Street, Suite 315A Hoboken, NJ 07030 Re: Anavex Life Sciences Corp. Form 10- K for the Fiscal Year Ended September 30, 2010 Filed December 27, 2010 File No. 000 -51652

Dear Dr. Durant :

We have completed our review of your Form 10- K and related filings and have no further comments at this time. Sincerely,

Melissa N. Rocha Accounting Branch Chief

Show Raw Text

March 22, 2011
 Dr. Cameron Durant
Executive Chairman and Director
Anavex Life Sciences Corp.
50 Harrison Street, Suite 315A
Hoboken, NJ 07030
Re:  Anavex Life Sciences Corp.
Form 10- K for the Fiscal Year Ended September 30, 2010
Filed December 27, 2010 File No. 000 -51652

Dear Dr. Durant :

We have completed our review of your Form 10- K and related filings and have no further
comments at this time.
 Sincerely,

Melissa N. Rocha
Accounting Branch Chief

SecProbe.io